7R90 Stock Chart & Stats
€2.62
€0.00(0.00%)
At close: 4:00 PM EDT
€2.62
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€2.63 - €5.65
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€20.48M
Enterprise Value€28.81
Total Cash (Recent Filing)€577.33K
Total Debt (Recent Filing)€39.56K
Price to Earnings (P/E)―
Beta3.63
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.44
Shares Outstanding21,108,885
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
RoboShare Commercial PivotThe pivot toward physical AI robotics gives the company a clearer commercial focus than its prior digital-asset strategy. RoboShare has moved beyond development into a paid deployment, creating an early operating proof point and a basis for testing repeat demand, economics, and expansion.
Asset-light Expansion ModelAn asset-light supply model can let RoboShare expand robot availability without purchasing the full fleet itself. Using previously sold and third-party equipment may reduce capital intensity, improve marketplace flexibility, and support geographic growth if rental demand and utilization develop as planned.
Sequential Cost DisciplineThe sequential reduction in operating expenses demonstrates that management has begun reallocating resources and controlling discretionary spending during commercialization. If this lower cost base persists, it could extend financial flexibility and reduce the revenue scale needed for the robotics strategy to approach sustainability.
Bears Say
Severely Constrained LiquidityVery limited cash materially restricts the company’s ability to fund operations, product development, and marketplace expansion without additional financing or asset sales. Management’s going-concern warning makes liquidity a durable execution constraint and could force slower pilot growth or difficult capital-allocation decisions.
No Meaningful Revenue And Persistent LossesThe company has yet to establish a durable revenue engine, while losses have worsened from 2024 through the TTM period. Continued negative operating earnings and absent gross-profit support indicate that commercialization remains unproven and that substantial funding may be required before scale benefits emerge.
Digital-asset Treasury LossesThe large unrealized decline in digital assets weakens the company’s asset base and introduces earnings volatility unrelated to its emerging robotics operations. Treasury losses can also reduce resources available for RoboShare and make financial planning more difficult while the company transitions its business model.
AIxCrypto Holdings News
7R90 FAQ
What was AIxCrypto Holdings’s price range in the past 12 months?
AIxCrypto Holdings lowest stock price was €2.63 and its highest was €5.65 in the past 12 months.
What is AIxCrypto Holdings’s market cap?
AIxCrypto Holdings’s market cap is €20.48M.
When is AIxCrypto Holdings’s upcoming earnings report date?
AIxCrypto Holdings’s upcoming earnings report date is Apr 01, 2027 which is in 190 days.
How were AIxCrypto Holdings’s earnings last quarter?
AIxCrypto Holdings released its earnings results on Aug 07, 2026. The company reported -€0.18 earnings per share for the quarter.
Is AIxCrypto Holdings overvalued?
According to Wall Street analysts AIxCrypto Holdings’s price is currently Overvalued.
Does AIxCrypto Holdings pay dividends?
AIxCrypto Holdings does not currently pay dividends.
What is AIxCrypto Holdings’s EPS estimate?
AIxCrypto Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIxCrypto Holdings have?
AIxCrypto Holdings has 21,108,885 shares outstanding.
What happened to AIxCrypto Holdings’s price movement after its last earnings report?
AIxCrypto Holdings reported an EPS of -€0.18 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AIxCrypto Holdings?
Currently, no hedge funds are holding shares in DE:7R90
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AIxCrypto Holdings
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
7R90 Company Deck
7R90 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Negative
The call highlighted meaningful operational progress: the public launch of the RoboShare marketplace, an LA pilot targeted to begin in August, an asset-light second-life strategy for robots, sequential cost reductions and internal AI Agent testing. However, the company faces material near-term challenges: constrained liquidity with only $577K cash, large unrealized digital-asset losses, significant YTD cash burn and no material recognized revenue yet (revenues contingent on pilot execution). Year-over-year operating expense increases and a larger quarterly net loss versus the prior year further weigh on the outlook. While management has taken steps to reduce expenses and retain share count, the combination of limited cash runway and deferred strategic initiatives creates significant execution risk.View all DE:7R90 earnings summaries